WIN symposium

The Worldwide Innovative Networking (WIN) Consortium announces the WIN 2012 Symposium, to be held in Paris, June 28-29, 2012. This symposium will be the next in the successful series of annual meetings dedicated to personalized cancer medicine. The WIN Consortium was created to accelerate the pace and reduce the cost of translating effective cancer treatments to the bedside. The WIN 2012 Symposium provides an open forum for discussion between all stakeholdere in cancer biomarkers and therapeutics development and great networking opportunities for everyone involved in improving cancer patient care at the level of the individual patient.

The main theme of the 2012 symposium, Efficacy of biomarkers and personalized cancer therapeutics, will be elaborated in various plenary sessions, bringing togeteher a unique assembly of high-ranking experts from academia, industry and regulatory agencies wordwide as speakers and moderators.

+ show speakers and program
I invite you to attend the WIN2012 symposium, to be held in Paris on June 28-29. You will not regret. It will be a unique scientific event and a fabulous network opportunity and enjoyable moment to know each others .10 members of the this network are guest speakers, Stephen Friend, John Quackenbush, Richard Gaynor, Steven Averbuch, and others..

Plan your travel and register now at www.winconsortium.org June, the 28-29th since June is a busy period in Paris. Save money since early registration close next week

I would very much appreciate your help to spread information about this WIN2012 symposium. It would just take you few minutes to post a short message through your networks. For me it would be a tremendous help to enhance visibility of this action.

Some useful informations about WIN consortium and symposium that I hope will raise your curiosity:

WIN Consortium, initiated by UT MDAnderson Cancer Centre, (Houston, USA), and Cancer Institute Gustave Roussy (Paris France), is a network of 17 anticancer centres across the globe, and three major industry partners Agilent, Technologies, Life gtechnologies and GE Healtcare, committed all to improving cancer personalized therapeutics. From Segal in Canand , Val d’Hebron-Spain, to Fudan –Shanghai, , from Barretos-Brazil to Chaim Sheba in Israel, this network is willing to meet with you

Consortium is opened for new members that are willing to join efforts to improve cancer patients care.

28 Jun - 29 Jun 2012
Paris
France
meeting website